ADNI3

Jun 28, 2018

What is the ADNI3?

For the last 12 years the Alzheimer’s Disease Neuroimaging Initiative has enrolled more than 800 patients and lead to significant advances in our understanding of Alzheimer’s Disease. Now in its 3rd iteration, ADNI3 will advance our understanding of how amyloid and Tau cause changes during the early stages of Alzheimer’s disease, MCI and cognitively normal cohort.

Join us in the movement to create a more dementia friendly Nevada! We are currently looking to schedule community screenings in September, October and November of 2018. Churches, clinics and health fairs are welcomed. To arrange a screening, please email Isaac Santa-Ana at santai@ccf.org or call (702)-685-7072.